Literature DB >> 9730393

A surgical option for familial chylomicronemia associated with insulin-resistant diabetes mellitus.

M Castagneto1, A De Gaetano, G Mingrone, E Capristo, G Benedetti, R M Tacchino, A V Greco, G Gasbarrini.   

Abstract

BACKGROUND: The goal of the present work is to present an effective surgical approach for the treatment of a medically-resistant form of hyperlipidemia.
METHODS: Two siblings with familial lipoprotein-lipase deficiency and subsequent hyperchylomicronemia, widespread skin xanthomas and severe insulin-resistant diabetes mellitus came to our observation after several unsuccessful attempts at medical treatment. In order to lower plasma lipids through lipid malabsorption, a modified bilio-pancreatic diversion operation was employed. The rationale in deciding to use this surgical approach was based also on the likely hypothesis that diabetes, in these subjects, was secondary to high circulating and tissue levels of lipids. Insulin sensitivity in the two treated subjects, as well as in 24 healthy volunteers constituting the control group, was assessed by euglycemic hyperinsulinemic clamp and indirect calorimetry, obtaining total end-clamp glucose uptake (M) and end-clamp glucose oxidation (ECGO) rates.
RESULTS: Within 3 weeks of surgery, plasma triglycerides and cholesterol levels had decreased from 4500 and 500 mg/dl (with dietary restrictions) to lower than 450 and 150 mg/dl (on a free, lipid-rich diet) respectively. Fasting plasma glucose levels had decreased from above 300 (under daily repeated subcutaneous injections of insulin) to 80-100 mg/dl (without administration of insulin or oral hypoglycemic agents). Body weight and fat free mass were maintained in both subjects after surgery. In both patients, before surgery M and ECGO were significantly lower than in normal subjects, while after surgery they were not significantly different from normal subjects, confirming the positive metabolic effect of the operation.
CONCLUSION: The surgical option used in these patients may represent an interesting and effective new possibility for treatment of those severe cases of hyperlipemia leading otherwise to metabolic complications and a low quality of life.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730393     DOI: 10.1381/096089298765554809

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  6 in total

1.  Gastric bypass surgery in non-obese patients with type 2 diabetes mellitus: a 1-year follow-up of 58 cases in Chinese.

Authors:  Jian-Feng Cui; Tao Chen; Li Shi; Hong-Tao Yan; Li-Jun Tang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Gut feelings about diabetes.

Authors:  Blandine Laferrère
Journal:  Endocrinol Nutr       Date:  2012-03-03

3.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 4.  Diabetes is predominantly an intestinal disease.

Authors:  Debmalya Sanyal
Journal:  Indian J Endocrinol Metab       Date:  2013-10

5.  A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion.

Authors:  Gabriella Nosso; Brunella Capaldo; Sara Cocozza; Olga Vaccaro
Journal:  Clin Case Rep       Date:  2015-11-05

Review 6.  Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy.

Authors:  Oluwayemisi Esan; Anthony S Wierzbicki
Journal:  Drug Des Devel Ther       Date:  2020-07-06       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.